Jordan Hanberry, MD
Urology · Pine Bluff, ARNPI 1447756374
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Teleflex LLC at 46.2% of the total. 2025 is the largest year on record at $8,588, 7.2 times the $1,185 reported in 2021.
Across 180 payments — averaging $93.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$8K
- Boston Scientific$3K
- Coloplast$2K
- Intuitive Surgical$2K
- Axonics, Inc.$631
- Sumitomo Pharma America, Inc.$310
- plus $1K from 15 others
What the payments were for
- Consulting fees$4,21925%
- Travel & lodging$3,19219%
- Food & beverage$7,90047%
- Education$1,5009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 28 | $7,768 |
| Boston Scientific | 41 | $2,984 |
| Coloplast | 45 | $2,499 |
| Intuitive Surgical | 1 | $1,500 |
| Axonics, Inc. | 14 | $631 |
| Sumitomo Pharma America, Inc. | 14 | $310 |
| Procept Biorobotics Corporation | 4 | $233 |
| AbbVie | 9 | $190 |
| Medtronic | 6 | $119 |
| Preceptis Medical, Inc. | 1 | $107 |
| Myovant Sciences Inc. | 2 | $79 |
| KARL Storz Endoscopy-america | 1 | $72 |
| Myriad Genetic Laboratories, Inc. | 3 | $61 |
| Urogen Pharma, Inc. | 2 | $50 |
| Angiodynamics, Inc. | 2 | $50 |
| Photocure Inc | 2 | $31 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $30 |
| Astellas Pharma US Inc | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$6,264
- Barrigel$2,006
- DAVINCI XI$1,500
- RESTORELLE$707
- ALTIS$475
- Axonics$362
- Bulkamid$254
- GENERAL KIDNEY STONE DISEASE$248
- AquaBeam Robotic System$187
- TITAN$123
- AMBICOR$122
- Solyx SIS System$120
- GENERAL ERECTILE DYSFUNCTION$116
- AMS 700 CXR RTE KIT$109
- LithoVue$107
- Hummingbird Tympanostomy Tube System$107
How this compares
$16,811 in reported general payments places this provider in the 70th percentile of 88 urology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 114 | $55,137 |
| MyrbetriqMirabegron | 48 | $27,364 |
| Estradiol | 106 | $7,248 |
| Cefpodoxime Proxetil | 36 | $1,418 |
| Tamsulosin Hcl | 208 | $1,263 |
| Potassium Citrate ErPotassium Citrate | 14 | $1,229 |
| Trospium Chloride | 30 | $1,155 |
| Finasteride | 49 | $382 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $248 |
| Dutasteride | 20 | $223 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 68 | $193 |
| Ciprofloxacin Hcl | 45 | $163 |
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $99 |
| Levofloxacin | 15 | $92 |
| Oxycodone Hcl | 40 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $310 | $55,137114 claims |
| Astellas Pharma US IncMyrbetriq | $27 | $27,36448 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 88 urology providers in Arkansas.
Other urology in Pine Bluff
- David JacksPine Bluff$125K
- David LupoPine Bluff$20K
- Dennis JacksPine Bluff$20K
- Nickolas ScherzerPine Bluff$9K
- Nathan GreenPine Bluff$7K
- Donald MooneyLittle Rock$148K
- Timothy GoodsonLittle Rock$147K
- Ronald KuhnNorth Little Rock$138K
- Caleb BozemanLittle Rock$136K
- David CoussensLittle Rock$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.